In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Update: Brand-Name Companies Vs. Independents

Executive Summary

After a year of disappointments, many brand-name companies are retreating from generics businesses. Generic companies, for their part, still struggle with managed care.
Advertisement

Related Content

Authorized Generics: Band-Aid or Strategy?
Savoring Sabex: Sandoz' Play in Injectable Generics
In Generics, An Update on Reform
Reforming--Balancing, Ruining, Whatever--Hatch Waxman
Biogenerics Are Coming and They're Not the Generics We Know
A Precarious Union: Combining Proprietary and Generic Businesses
A Precarious Union: Combining Proprietary and Generic Businesses
Mylan's New Focus

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV000263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel